NIPBL and non-small cell lung carcinoma: Mechanically, NIPBL downregulation promotes autophagy and impairs DNA damage response of non-small cell lung cancer cells (Zheng et al., 2018), indicating that NIPBL may serve as a therapeutic target of chemotherapy resistance.